8-KThe WireRoutine
Reg FD Disclosure · Company Update
Filed Nov 8, 2019 · 6y ago · Accession 0001171843-19-007381
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Corvus Pharmaceuticals, Inc.
- Ticker
- CRVS
- CIK
- 1626971
- Form type
- 8-K
- Filing date
- Nov 8, 2019
- Report date
- Nov 8, 2019
- Document
- f8k_110819.htm
- Size
- 5.6 MB